Connection

Yuichi Sumii to Humans

This is a "connection" page, showing publications Yuichi Sumii has written about Humans.
Connection Strength

0.128
  1. Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study. Transfusion. 2023 11; 63(11):2120-2130.
    View in: PubMed
    Score: 0.022
  2. Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems. Transfusion. 2022 09; 62(9):1829-1838.
    View in: PubMed
    Score: 0.021
  3. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series. Int J Hematol. 2020 Dec; 112(6):780-786.
    View in: PubMed
    Score: 0.018
  4. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma]. Rinsho Ketsueki. 2018; 59(7):889-894.
    View in: PubMed
    Score: 0.015
  5. Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch. Transfusion. 2023 07; 63(7):1344-1353.
    View in: PubMed
    Score: 0.005
  6. Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony-stimulating factor for severe hypoxemia provoked by high-dose granulocyte colony-stimulating factor administration. Transfus Med. 2022 12; 32(6):527-529.
    View in: PubMed
    Score: 0.005
  7. Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia continuous mononuclear cell collection procedure. Transfusion. 2022 05; 62(5):1065-1072.
    View in: PubMed
    Score: 0.005
  8. Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells. Immunohorizons. 2021 06 10; 5(6):424-437.
    View in: PubMed
    Score: 0.005
  9. Donor Treg expansion by liposomal a-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. Immun Inflamm Dis. 2021 09; 9(3):721-733.
    View in: PubMed
    Score: 0.005
  10. Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplant. 2021 04; 56(4):956-959.
    View in: PubMed
    Score: 0.005
  11. 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2020 10 14; 10(1):17237.
    View in: PubMed
    Score: 0.005
  12. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient. Int J Hematol. 2020 Dec; 112(6):871-877.
    View in: PubMed
    Score: 0.004
  13. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy. Int J Hematol. 2020 Sep; 112(3):422-426.
    View in: PubMed
    Score: 0.004
  14. [Hyper-IL-6 syndrome mimicking IgG4-related disease]. Rinsho Ketsueki. 2019; 60(5):392-397.
    View in: PubMed
    Score: 0.004
  15. Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10. Rinsho Ketsueki. 2017; 58(2):161-164.
    View in: PubMed
    Score: 0.003
  16. Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J Biol Chem. 2005 Jul 15; 280(28):26371-82.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.